Mirati Therapeutics, Inc.
NASDAQ: MRTX
$39.54
-$1.18 (-2.9%)
Closing price March 22, 2023
Friday's top analyst upgrades and downgrades included Altice USA, AT&T, Ballard Power Systems, Bank of America, Lockheed Martin, Lowe’s Companies, Raytheon Technologies and Shopify.
3 months ago
Last Updated: 3 months ago
Tuesday’s additional top analyst upgrades and downgrades were on BHP, Booz Allen Hamilton, Devon Energy, Mirati Therapeutics, Novo Nordisk, NRG Energy and more.
9 months ago
Tuesday afternoon's top analyst upgrades and downgrades included Coupa Software, Ginkgo Bioworks, Enterprise Products Partners and Intuit.
1 year ago
Tuesday's top analyst upgrades and downgrades included BioNTech, ConocoPhillips, Harley-Davidson, Livent, Luminar Technologies, Meta Platforms, Moderna, Snap, Twitter, United Airlines, US Foods,...
1 year ago
Last Updated: 1 year ago
Thursday's top analyst upgrades and downgrades included Dick’s Sporting Goods, Fate Therapeutics, Kimberly-Clark, Nordstrom, Roblox, TJX Companies and Zoom Video Communications.
1 year ago
Last Updated: 1 year ago
Monday's top analyst upgrades and downgrades included Foot Locker, Halozyme Therapeutics, Kimberley-Clark, Occidental Petroleum, Texas Roadhouse, Trip.com and Williams Companies.
1 year ago
Last Updated: 1 year ago
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including At Home, Beyond Meat, Lyft, MoneyGram and Raytheon Technologies.
1 year ago
Monday's top analyst upgrades and downgrades included Advanced Micro Devices, Amgen, Asana, Baidu, First Solar, Mattel, Mirati Therapeutics, Palantir Technologies, Pinterest, SAP and Zscaler.
2 years ago
Last Updated: 2 years ago